Home › Funds › Alyeska Investment Group, L.P. › TEVA

Alyeska Investment Group, L.P. position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

Alyeska Investment Group, L.P. reported holding 6,257,579 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q2 2026 13F filing — a position valued at US$212.0M, representing 0.55% of its reported portfolio and ranking #33 among its reported holdings. Alyeska Investment Group, L.P. has disclosed TEVA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)6.26M sh
Reported value held$212.01M
Portfolio Weight0.55%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Alyeska Investment Group, L.P.'s TEVA position evolved

Alyeska Investment Group, L.P. first disclosed a stake in TEVA in Q3 2023 at 6,462,576 shares (US$65.9M). The position peaked in Q2 2026 at 6,257,579 shares, worth US$212.0M. Across 12 filings, Alyeska Investment Group, L.P. increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 6,257,579 shares valued at US$212.0M — an increase of 738,549 shares quarter over quarter.. Notable position changes include a 146% increase in Q3 2025 (shares rose 55% over the following quarter), a 41% trim in Q4 2025 (shares fell 3% over the following quarter), a 56% increase in Q1 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.46M $65.92M New
Q4 2023 5.46M $57.00M Reduce
Q1 2024 6.35M $89.54M Add
Q2 2024 3.83M $62.22M Reduce
Q3 2024 3.62M $65.32M Reduce
Q4 2024 3.64M $80.26M Hold
Q1 2025 3.23M $49.58M Reduce
Q2 2025 2.43M $40.73M Reduce
Q3 2025 5.98M $120.72M Add
Q4 2025 3.54M $110.36M Reduce
Q1 2026 5.52M $166.23M Add
Q2 2026 6.26M $212.01M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 42 other funds we track also report a position in TEVA — the largest reported positions include Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has Alyeska Investment Group, L.P. held TEVA?

Alyeska Investment Group, L.P. has disclosed TEVA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Alyeska Investment Group, L.P.'s current position in TEVA?

As of Q2 2026, Alyeska Investment Group, L.P. holds 6.26M shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $212.01M, representing 0.55% of its reported portfolio and ranking #33.

Has Alyeska Investment Group, L.P. been buying or selling TEVA?

In the latest 13F filing (Q2 2026), Alyeska Investment Group, L.P. increased its position in TEVA. The position peaked in Q2 2026 at 6.26M shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include Harel Insurance Investments & Financial Services Ltd., Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.